Top Breast Cancer Stories from October 2025

November 5th 2025, 10:00pm

By Ryan Scott

This year’s Breast Cancer Awareness Month highlighted FDA approvals, survivorship challenges and advances in breast reconstruction.

New Book Spotlights Cancer in Early Adulthood

November 5th 2025, 9:00pm

By Cristina Pozo-Kaderman

‘Coping With Cancer in Early Adulthood’ addresses issues of patients 18 to 49 years old.

Top Gastrointestinal Cancer News: October 2025

November 5th 2025, 8:00pm

By Spencer Feldman

Long-awaited progress in rectal and gastric cancer research includes a fast track designation and new survival data.

Hairy Cell Leukemia Experts Impart Advice on Care and Support

November 5th 2025, 6:00pm

By Dr. Dima El-Sharkawi

CURE attended the Hairy Cell Leukemia Foundation 2025 Conference where medical experts gathered to discuss advances in research and patient care.

Brachytherapy, Chemo, and Turner Syndrome: A Teen's Rare Cancer Battle

November 5th 2025, 5:00pm

By Gina Mauro

A young cancer survivor who underwent EBRT and brachytherapy at 14 discusses her rare diagnosis, side effects, and the non-link to her Turner syndrome.

FDA Grants Orphan Drug Designation to M2T-CD33 in AML

November 5th 2025, 4:00pm

By Alex Biese

The U.S. FDA has granted orphan drug designation to M2T-CD33 for the treatment of patients with acute myeloid leukemia.

Some Advice for Cancer Caregivers During National Caregiver Month

November 5th 2025, 2:00pm

By Debbie Legault

Basal Cell Carcinoma Basics, From Diagnosis to Treatment

November 4th 2025, 10:00pm

By Alex Biese

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable.

Stage 2 Cervical Cancer: Key Facts and Updates for Patients

November 4th 2025, 9:00pm

By Ryan Scott

This is an essential guide on stage 2 cervical cancer to support patients in discussing diagnosis, treatment, and care decisions with their oncology team.

HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide

November 4th 2025, 8:00pm

By Spencer Feldman

Learn how HR-positive/HER2-negative breast cancer is diagnosed, treated by stage and managed for side effects to guide patient-oncologist discussions.

So You Want To Be A Cancer Advocate

November 4th 2025, 6:00pm

By Martha Carlson

An 11-year survivor of stage 4 breast cancer explains that everyone has a role to play.

Areola Tattoos Help Patients Feel ‘As Normal as Possible’ After Breast Cancer

November 4th 2025, 5:00pm

By Alex Biese

CURE spoke with an areola tattoo artist and a patient who has undergone the procedure.

Voranigo Continues to Benefit Patients With Grade 2 IDH-Mutated Glioma

November 4th 2025, 4:00pm

By Spencer Feldman

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation.

Experts Urge Greater Awareness and Support as Liver Cancer Month Ends

November 4th 2025, 2:00pm

By Dr. Arndt Vogel

As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and resources for liver cancer.

Finding Humor in a Cancer Journey

November 3rd 2025, 10:00pm

By Alyce Harris

A cancer survivor explains how humor helped her during her cancer journeys.